Drug-specific in vitro release of IL-2, IL-5, IL-13 and IFN-γ in patients with delayed-type drug hypersensitivity

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 64, Issue 9, 2009, Pages 1269-1278

  Lochmatter, P ^a   Beeler, A ^a   Kawabata, T T ^b   Gerber, B O ^a   Pichler, W J ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b PFIZER INC   (United States)

Author keywords

lactam; Cytokine secretion; Drug hypersensitivity; Sulfanilamide; T cells

Indexed keywords

AMOXICILLIN; AMPICILLIN; BETA LACTAM; CHEMOKINE; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 13; INTERLEUKIN 2; INTERLEUKIN 5; SULFAMETHOXAZOLE; SULFANILAMIDE; SULFAPYRIDINE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; DRUG HYPERSENSITIVITY; FEMALE; HUMAN; IMMUNOASSAY; IN VITRO STUDY; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; T LYMPHOCYTE;

ADULT; AGED; BETA-LACTAMS; CELLS, CULTURED; CYTOKINES; DRUG HYPERSENSITIVITY; FEMALE; HUMANS; HYPERSENSITIVITY, DELAYED; INTERFERON-GAMMA; INTERLEUKIN-13; INTERLEUKIN-2; INTERLEUKIN-5; MALE; MIDDLE AGED; SKIN TESTS; SULFANILAMIDES; T-LYMPHOCYTES;

EID: 68949205913     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/j.1398-9995.2009.01985.x     Document Type: Article

References (23)

1. Pichler WJ. Delayed drug hypersensitivity reactions. Ann Intern Med 2003 139 : 683 693.
2. Pichler WJ. Drug hypersensitivity. Basel, Karger, 2007.
3. Pichler WJ. Immune mechanism of drug hypersensitivity. Immunol Allergy Clin North Am 2004 24 : 373 397, v vi.
4. Torres MJ, Blanca M, Fernandez J, Romano A, Weck A, Aberer W et al. Diagnosis of immediate allergic reactions to beta-lactam antibiotics. Allergy 2003 58 : 961 972.
5. Romano A, Blanca M, Torres MJ, Bircher A, Aberer W, Brockow K et al. Diagnosis of nonimmediate reactions to beta-lactam antibiotics. Allergy 2004 59 : 1153 1160.
6. Aberer W, Bircher A, Romano A, Blanca M, Campi P, Fernandez J et al. Drug provocation testing in the diagnosis of drug hypersensitivity reactions: general considerations. Allergy 2003 58 : 854 863.
7. Pichler WJ, Tilch J. The lymphocyte transformation test in the diagnosis of drug hypersensitivity. Allergy 2004 59 : 809 820.
8. Beeler A, Zaccaria L, Kawabata T, Gerber BO, Pichler WJ. CD69 upregulation on T cells as an in vitro marker for delayed-type drug hypersensitivity. Allergy 2008 63 : 181 188.
9. Merk HF. Diagnosis of drug hypersensitivity: lymphocyte transformation test and cytokines. Toxicology 2005 209 : 217 220.
10. Sachs B, Erdmann S, Al-Masaoudi T, Merk HF. In vitro drug allergy detection system incorporating human liver microsomes in chlorazepate-induced skin rash: drug-specific proliferation associated with interleukin-5 secretion. Br J Dermatol 2001 144 : 316 320.
11. Cederbrant K, Marcusson-Stahl M, Hultman P. Characterization of primary recall in vitro lymphocyte responses to bacampicillin in allergic subjects. Clin Exp Allergy 2000 30 : 1450 1459.
12. Sachs B, Erdmann S, Malte Baron J, Neis M, al Masaoudi T, Merk HF. Determination of interleukin-5 secretion from drug-specific activated ex vivo peripheral blood mononuclear cells as a test system for the in vitro detection of drug sensitization. Clin Exp Allergy 2002 32 : 736 744.
13. Halevy S, Cohen AD, Grossman N. Clinical implications of in vitro drug-induced interferon gamma release from peripheral blood lymphocytes in cutaneous adverse drug reactions. J Am Acad Dermatol 2005 52 : 254 261.
14. Halevy S, Cohen AD, Livni E. The diagnostic role of the in vitro drug-induced interferon-gamma release test in Stevens-Johnson syndrome. Int J Dermatol 1999 38 : 835 840.
15. Halevy S, Gold I, Cohen AD, Grossman N. In vitro interferon-gamma release test in the diagnosis of drug-induced erythema nodosum. Isr Med Assoc J 2004 6 : 59 60.
16. Barbaud A, Goncalo M, Bruynzeel D, Bircher A. Guidelines for performing skin tests with drugs in the investigation of cutaneous adverse drug reactions. Contact Dermatitis 2001 45 : 321 328.
17. Beeler A, Engler O, Gerber BO, Pichler WJ. Long-lasting reactivity and high frequency of drug-specific T cells after severe systemic drug hypersensitivity reactions. J Allergy Clin Immunol 2006 117 : 455 462.
18. Nyfeler B, Pichler WJ. The lymphocyte transformation test for the diagnosis of drug allergy: sensitivity and specificity. Clin Exp Allergy 1997 27 : 175 181.
19. Yang CS, Lee JS, Lee HM, Shim TS, Son JW, Jung SS et al. Differential cytokine levels and immunoreactivities against Mycobacterium tuberculosis antigens between tuberculous and malignant effusions. Respir Med 2008 102 : 280 286.
20. de Silva HD, Gardner LM, Drew AC, Beezhold DH, Rolland JM, O'Hehir RE. The hevein domain of the major latex-glove allergen Hev b 6.01 contains dominant T cell reactive sites. Clin Exp Allergy 2004 34 : 611 618.
21. Beeler A, Pichler WJ. In vitro tests of T cell mediated drug hypersensitivity. Expert Rev Clin Immunol 2006 2 : 887 900.
22. Halevy S, Cohen A, Livni E. Acute generalized exanthematous pustulosis associated with polysensitivity to paracetamol and bromhexine: the diagnostic role of in vitro interferon-gamma release test. Clin Exp Dermatol 2000 25 : 652 654.
23. Mauri-Hellweg D, Bettens F, Mauri D, Brander C, Hunziker T, Pichler WJ. Activation of drug-specific CD4+ and CD8+ T cells in individuals allergic to sulfonamides, phenytoin, and carbamazepine. J Immunol 1995 155 : 462 472.